메뉴 건너뛰기
BJU International
Volumn 99, Issue SUPPL. 1, 2007, Pages 10-12
Global update on defining and treating high-risk localized prostate cancer with leuprorelin: A Japanese perspective - The effect of primary androgen deprivation therapy on stage C prostate cancer
Author keywords

High risk; Hormone therapy; Japan; Leuprorelin; Prostate cancer
Indexed keywords

BICALUTAMIDE; GONADORELIN AGONIST; LEUPRORELIN; PLACEBO;
EID: 33845653202     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.06593.x     Document Type: Conference Paper
Times cited : (4)
References (4)
  • 1
    • 14744299390 scopus 로고    scopus 로고
    • Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association
    • Cancer Registration Committee of the Japanese Urological Association
    • Cancer Registration Committee of the Japanese Urological Association. Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association. Int J Urol 2005; 12: 46-61
    • (2005) Int J Urol , vol.12 , pp. 46-61
  • 2
    • 6044231016 scopus 로고    scopus 로고
    • Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP Surveillance
    • Akaza H, Usami M, Hinotsu S et al. Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP Surveillance. Jpn J Clin Oncol 2004; 34: 329-36
    • (2004) Jpn J Clin Oncol , vol.34 , pp. 329-336
    • Akaza, H.1    Usami, M.2    Hinotsu, S.3
  • 3
    • 33746880261 scopus 로고    scopus 로고
    • Efficacy of primary hormone therapy for localized or locally advanced prostate cancer: Results of a 10-year follow-up
    • Akaza H, Homma Y, Usami M et al. Efficacy of primary hormone therapy for localized or locally advanced prostate cancer: results of a 10-year follow-up. BJU Int 2006; 98: 573-9
    • (2006) BJU Int , vol.98 , pp. 573-579
    • Akaza, H.1    Homma, Y.2    Usami, M.3
  • 4
    • 1842863545 scopus 로고    scopus 로고
    • Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: Interim results of a randomized study in Japanese patients
    • Akaza H, Yamaguchi A, Matsuda T et al. Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study in Japanese patients. Jpn J Clin Oncol 2004; 34: 20-8
    • (2004) Jpn J Clin Oncol , vol.34 , pp. 20-28
    • Akaza, H.1    Yamaguchi, A.2    Matsuda, T.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.